Medication info
Duca M Tablet 60/5 mg (Pimasartan Potassium, Esamlodipine)

Duca M Tablet 60/5 mg (Pimasartan Potassium, Esamlodipine)

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›66.01mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›7.48mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
Orange-colored, square film-coated tablet with rounded corners
Packaging
30 tablets / bottle, 300 tablets / bottle
Approval status
Active

MFDS item code 202300106 · Approved 2023.01.06 · Insurance code 622804950

Summary

Main use
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take this medicine at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended to adjust the dose of fimasartan; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Older adults No initial dose adjustment is required for older adults aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with fimasartan monotherapy

  • Essential Hypertension
View approved original text

This medication may be needed for patients with essential hypertension who cannot adequately control blood pressure with Pimasartan Potassium alone. This drug is used to treat essential hypertension and effectively lowers blood pressure, helping to prevent cardiovascular complications. Therefore, it is used to improve blood pressure control in patients with essential hypertension.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take this medicine at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended to adjust the dose of fimasartan; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Older adults No initial dose adjustment is required for older adults aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Do not take this medication if you are allergic to any of its active ingredients or dihydropyridine derivatives, if you are pregnant or nursing, if you are receiving renal dialysis, if you have moderate to severe liver impairment, if you have biliary obstruction, if you have specific kidney function disorders related to diabetes, or if you have genetic issues like lactose intolerance. Patients with low blood volume or body salt, impaired kidney function, renovascular hypertension, certain heart valve diseases, severe hypotension, elderly individuals, etc., should be particularly cautious when taking this medication and it should be administered while closely monitoring their condition. While using this medication, side effects such as dizziness, headache, facial or peripheral edema, urination disorders, insomnia, and flushing may occur, so consult a doctor if any abnormal symptoms appear. In particular, blood pressure may become too low or electrolyte imbalances may occur, so blood pressure and electrolyte status should be checked periodically at the start of treatment or when adjusting the dosage. This medication may interact with other antihypertensives, potassium-sparing diuretics, lithium preparations, NSAIDs, etc., so inform your doctor or pharmacist if you are taking any other medications. Pregnant or nursing women are advised not to take this medication, and it should only be decided after consulting a specialist if necessary. The safety and efficacy of this medication in children under 18 years of age have not been established, and extra caution is necessary for elderly individuals over 70 years of age. In case of overdose, hypotension, palpitations, and in severe cases, shock may occur, necessitating immediate hospital visit and possible emergency treatment. This medication should be kept out of the reach of children, and transferring it to other containers can affect quality, so care should be taken.

Side effects

Dizziness, orthostatic dizziness, headache, facial swelling, peripheral edema, urinary disorders, insomnia, flushing, fainting, sedation, migraine, dyspepsia, vomiting, nausea, upper abdominal pain, weakness, foreign body sensation, elevated liver enzyme levels, decreased platelet count, increased serum creatine phosphokinase, cough, muscle contraction, musculoskeletal rigidity, itching, localized urticaria, facial flushing, erectile dysfunction, epilepsy, amyotrophic lateral sclerosis, neuropathy, neuronitis, facial paralysis, normal pressure hydrocephalus, spinal stenosis, acute pancreatitis, intestinal obstruction, hemorrhagic duodenal ulcer, appendicitis, hemorrhoids, abdominal pain, intracranial hemorrhage, transient ischemic attack, atherosclerosis, worsening cerebral infarction, cerebral hemorrhage, liver cancer, colon cancer, neoplasm of unspecified nature, cervical cancer, prostate cancer, acute renal failure, chronic renal failure, kidney stones, pyelonephritis, urinary incontinence, rhinitis, fibrosing alveolitis, pharyngitis, pneumonia, pulmonary disease, death, exacerbation of low back pain, osteoarthritis, arthritis, hypoglycemia, hyperkalemia, pulmonary embolism, purpura, bradycardia, atrial fibrillation, coronary artery disease, aortic stenosis, heart failure, elevation of blood pressure, acute hepatitis, benign pituitary neoplasm, otitis media, uterine prolapse, recurrent cancer, cerebral infarction, fracture, chest pain, weakness, fatigue, pain, weight gain, weight loss, hypotension, vasculitis, tension dysregulation, sensory impairment, sensory abnormalities, peripheral neuropathy, taste disorder, tremor, extrapyramidal disorder, gynecomastia, change in bowel habits, dry mouth, dyspepsia, gingival hypertrophy, pancreatitis, sweating, hair loss, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, nocturia, hepatitis, jaundice, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, chest pain, hypotension, sinus block, atrioventricular block, abdominal discomfort, substernal pain, diarrhea, loose stools, constipation, skin redness and pain, maculopapular rash, heaviness, heat sensation, impaired glucose tolerance, weakness, symptoms of hypotension due to depletion of blood volume and sodium, increased serum potassium level, increased serum creatinine, increased blood urea, decreased blood pressure, shock symptoms, loss of consciousness, dyspnea, severe hypotension, pulmonary edema, hypotension, drowsiness, palpitations, dizziness, abdominal pain, nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in an opaque container that does not allow light in. Additionally, it is best to store the medication at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness over time.

Appearance and packaging

Appearance

Orange-colored, square film-coated tablet with rounded corners

Package unit

30 tablets / bottle, 300 tablets / bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.